Cognition Therapeutics Inc (CGTX) — Capital Reinvestment Ratio

Latest as of December 2021: 0.27x

Cognition Therapeutics Inc (CGTX) has a Capital Reinvestment Ratio of 0.27x as of December 2021, meaning it reinvests 0% of its operating cash flow ($101.00K) in capital expenditures ($27.00K). See CGTX equity financing ratio to measure how much of total assets are equity-financed.

Capital Reinvestment Ratio

0.27x

Capex / Operating Cash Flow

Operating Cash Flow

$101.00K

USD

Capital Expenditures

$27.00K

USD

Data as of

Dec 2021

Most recent filing

Annual Capital Reinvestment Ratio for Cognition Therapeutics Inc (None–None)

Year-by-year Capital Reinvestment Ratio for Cognition Therapeutics Inc from None to None. For live market cap and broader valuation context, see Cognition Therapeutics Inc market capitalisation.

Year	Reinvestment Ratio	Operating CF (USD)	Capital Expenditures	YoY Change

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow